HOTHbenzinga

Hoth Therapeutics Has Been Granted U.S. Patent No. 12,144,815 Titled USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE.

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on November 19, 2024 by benzinga